98%
921
2 minutes
20
Background: Osteoarthritis is the most common form of arthritis, causing pain, functional disability, and a reduction in terms of quality of life. Minimally invasive treatments like intra-articular hip injections are a therapeutic option and ultrasound guidance might improve the results of these injections.
Objective: To summarize the evidence about the effectiveness of ultrasound-guided hip injections in terms of pain and functioning in patients affected by hip osteoarthritis.
Methods: A systematic search of the literature was performed on three electronic databases: PubMed, Cochrane and PEDro, using a specific search strategy. We evaluated for inclusion all articles according to the following participants, intervention, comparison, and outcomes (PICO) model: P) Population: human patients affected by hip osteoarthritis; I) Intervention: intra-articular hip injections performed with a ultrasound-guidance; C) Comparator: sham therapy or every other conservative or oral, non-invasive, minimally invasive or surgical technique; O) Outcome measures: pain assessed by Visual Analogue Scale (VAS) or Numerical Rating Scale (NRS); functional outcomes.
Results: At the end of the search, 43 articles were included in the review. Several drugs have been considered in the included studies: hyaluronic acid, platelet-rich plasma, corticosteroids, micro-fragmented adipose tissue, bone marrow concentrates, amniotic suspension allograft.
Conclusion: Ultrasound-guided injections of hyaluronic acid might be effective on pain relief and functioning in patients affected by hip osteoarthritis. Also, other rehabilitative infiltrative techniques (i.e., corticosteroids and platelet-rich plasma) showed a positive effect in the short-term period.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/10538127241296338 | DOI Listing |
BMC Musculoskelet Disord
September 2025
Department of Sports Medicine and Medical Rehabilitation, Sechenov First Moscow State Medical University, Bolshaya Pirogovskaya street 2 building 9, Moscow, 119435, Russia.
Purpose: To assess research directions of the Mesenchymal stem cells (MSCs) injections in traumatology and orthopaedics.
Methods: The study monitored the protocols of randomised controlled trials (RCTs) and systematic reviews (SRs) investigating mesenchymal stem cell (MSC) injections for various traumatological and orthopaedic conditions. Relevant RCT protocols were identified through searches of ClinicalTrials.
Cureus
August 2025
Anesthesiology, University of Maryland Medical Center, Baltimore, USA.
Sacroiliac joint dysfunction (SIJD) is a significant contributor to lower back pain, and the condition often mimics other lower back pain syndromes, necessitating accurate diagnosis through history, physical examination, provocative tests, and imaging studies. We present a 67-year-old man with a history of sarcoidosis, deep vein thrombosis, prostate cancer, and chronic low back pain, who experienced persistent right-sided back and hip pain despite multiple surgeries, including bilateral sacroiliac joint (SIJ) fusion. Conservative treatments provided only partial relief.
View Article and Find Full Text PDFJ Orthop
December 2025
Hospital for Special Surgery, New York, NY, USA.
Background: Robotic assistance in total hip arthroplasty (THA) has increased, but the influence on outcomes compared to manual THA remains uncertain. With the growing emphasis on reducing opioid consumption after arthroplasty, we studied whether robotic assistance was associated with length of stay (LOS), pain, and opioid use after THA.
Materials And Methods: We included 14,501 opioid-naïve patients who underwent THA at a single institution between 2019 and 2023 (8900 manual and 5601 robotic).
J Med Life
July 2025
Department of Orthopaedics, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Osteonecrosis of the femoral head (ONFH) is a challenging condition that mainly affects young and middle-aged adults, causing pain, disability, and joint collapse. Current treatment options include medications, physical therapy, and surgical interventions such as core decompression and total hip replacement. However, there is growing interest in regenerative medicine for managing ONFH.
View Article and Find Full Text PDFVideo J Sports Med
August 2025
Department of Orthopaedic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Background: While there have been many advances in the treatment of labral pathology in the hip over the past decade, there are still questions regarding the treatment of chondral lesions in the hip. In this video, we highlight one such technique for harvesting and using bone marrow aspirate concentrate (BMAC) during hip arthroscopy.
Indications: BMAC as supplementation is indicated for patients with hip chondrolabral pathology in the setting of femoroacetabular impingement.